Given that the PDK-4 inhibition is beneficial both in diabetes [53] and vascular calcification [33], it is reasonable to assume that lowering the PDK-4 activity might have a dual positive effect on diabetic vascular calcification. The gene discussed is PDK4; the disease is calcification.